Sophie Paczesny MD
Cancer Genetics/Cancer Risk Assessment, Pediatric Hematologic Oncology
Associate Professor Indiana University School of Medicine
Join to View Full Profile
1044 W. Walnut StreetR4-425Indianapolis, IN 46202
Phone+1 317-278-5487
Dr. Paczesny is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Sophie Paczesny is a pediatric hematologist/oncologist in Indianapolis, IN. She received her medical degree from University of Paris VII Faculty of Medicine and has been in practice 21 years. She specializes in cancer genetics/cancer risk assessment and pediatric hematologic oncology.
Education & Training
University of Paris VII Faculty of MedicineClass of 1995
Clinical Trials
- Bridging Pediatric and Adult Biomarkers in Graft-Versus-Host Disease Start of enrollment: 2014 Jan 01
- Sinusoidal Obstruction Syndrome for Stem Cell Transplant Patients Biomarker Study Start of enrollment: 2017 Apr 01
Publications & Presentations
PubMed
- 22 citationsNumber of HLA mismatched eplets is not associated with major outcomes in haploidentical transplantation with post-transplantation cyclophosphamide: A Center for Intern...Jun Zou, Tao Wang, Meilun He, Yung-Tsi Bolon, Shahinaz M. Gadalla
Transplantation and Cellular Therapy. 2021-11-10 - 67 citationsHLA Informs Risk Predictions after Haploidentical Stem Cell Transplantation with Post-transplantation Cyclophosphamide.Ephraim J. Fuchs, Shannon R. McCurdy, Scott R. Solomon, Tao Wang, Megan M. Herr
Blood. 2021-11-01 - 2 citationsDonor Killer Immunoglobulin Receptor Gene Content and Ligand Matching and Outcomes of Pediatric Patients with Juvenile Myelomonocytic Leukemia Following Unrelated Dono...Hemalatha G. Rangarajan, Marcelo S.F. Pereira, Ruta Brazauskas, Andrew St. Martin, Ashleigh Kussman
Transplantation and Cellular Therapy. 2021-11-01
Journal Articles
- Upper Gastrointestinal Acute Graft-Versus-Host Disease Adds Minimal Prognostic Value in Isolation or with Other Graft-Versus-Host Disease Symptoms as Currently Diagnos...Margaret MacMillan, Sophie Paczesny, Ran Reshef, Daniel Weisdorf, Haematologica
- From Proteomics to Discovery of First-in-Class ST2 Inhibitors Active in VivoSophie Paczesny, MD, The Journal of Clinical Investigation
Press Mentions
- Risk Biomarkers May Be Used to Anticipate Severe Stem Cell Transplant Adverse Effects: ResearchMay 28th, 2023
- Risk Biomarkers Could Predict Serious Side Effect of Stem Cell TransplantMay 22nd, 2023
Golden Appointed to Diversity, Inclusion and Equity CommitteeMarch 29th, 2021- Join now to see all
Grant Support
- Machine Learning to identify Biomarkers for Risk of Chronic Graft-Versus-Host DiseaseMEDICAL UNIVERSITY OF SOUTH CAROLINA2021–2026
- Chronic Graft-Versus-Host Disease Biomarkers: Prediction of Resistance to TherapyMEDICAL UNIVERSITY OF SOUTH CAROLINA2023–2025
- Chronic Graft-Versus-Host Disease Biomarkers: Prediction of Resistance to TherapyMEDICAL UNIVERSITY OF SOUTH CAROLINA2023–2025
- Chronic Graft-Versus-Host Disease Biomarkers: Prediction of Resistance to TherapyMEDICAL UNIVERSITY OF SOUTH CAROLINA2023–2025
- Chronic Graft-Versus-Host Disease Biomarkers: Prediction of Resistance to TherapyMEDICAL UNIVERSITY OF SOUTH CAROLINA2023–2025
- Chronic Graft-Versus-Host Disease Biomarkers: Prediction of Resistance to TherapyMEDICAL UNIVERSITY OF SOUTH CAROLINA2023–2025
- Chronic Graft-Versus-Host Disease Biomarkers: Prediction of Resistance to TherapyMEDICAL UNIVERSITY OF SOUTH CAROLINA2023–2025
- IL-33 induced-lL-9 producing type 2 innate lymphoid cells in the regulation of acute lung injury after hematopoietic stem cell transplantation (HSCT) in pediatric patientsMEDICAL UNIVERSITY OF SOUTH CAROLINA2022–2025
- Translating Novel Drug-Targetable Biomarkers to Treat Graft versus Host DiseaseMEDICAL UNIVERSITY OF SOUTH CAROLINA2013–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
